Radioimmun therapy with (90)Y-Ibritumomab tiuxetan in patients with non-hodgkin's lymphoma

Basit Öğe Kaydı
dc.contributor.authorKaya, H.
dc.contributor.authorAyyildiz, O.
dc.contributor.authorAltunci, G. Kaya
dc.contributor.authorBellur, B. Kizilkan
dc.contributor.authorIsikdogan, A.
dc.date.accessioned2024-04-24T17:44:28Z
dc.date.available2024-04-24T17:44:28Z
dc.date.issued2009
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS420en_US
dc.identifier.issn1619-7070
dc.identifier.startpageS420en_US
dc.identifier.urihttps://hdl.handle.net/11468/22087
dc.identifier.volume36en_US
dc.identifier.wosWOS:000208690802205
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Journal of Nuclear Medicine and Molecular Imaging
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleRadioimmun therapy with (90)Y-Ibritumomab tiuxetan in patients with non-hodgkin's lymphomaen_US
dc.titleRadioimmun therapy with (90)Y-Ibritumomab tiuxetan in patients with non-hodgkin's lymphoma
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu